These compounds may interact with:
Serine/threonine-protein kinase PAK 4
Potentially involved in: carcinoma; cancer; breast adenoma; atypical teratoid / rhabdoid tumor; glioblastoma; malignant mesothelioma; medulloblastoma, large-cell; osteosarcoma
Disease data sourced from Pharos.